EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
BioNTech (NASDAQ:BNTX) Trading Down 2.2% - Here's What Happened
BioNTech (NASDAQ:BNTX) Trading Down 2.2% – Here’s What Happened
Is BioNTech SE (BNTX) the Best German Stock to Buy Now?
BioNTech (NASDAQ:BNTX) Trading 4.9% Higher - Still a Buy?
Evercore ISI upgrades BioNTech, says 'chaos' of RFK Jr.'s nomination presents buying opportunity
BioNTech (NASDAQ:BNTX) Raised to "Outperform" at Evercore ISI
Berenberg sees upside in BioNTech stock—cancer pipeline momentum through 2025 By Investing.com
Berenberg Bank Begins Coverage on BioNTech (NASDAQ:BNTX)
BioNTech stock upgraded as Evercore ISI highlights undervaluation and growth By Investing.com
Other news to note for November 19, 2024 | BioWorld
BioNTech's (BNTX) "Buy" Rating Reiterated at HC Wainwright
Goldman Sachs Reaffirms Their Buy Rating on BioNTech SE (BNTX)
FY2024 EPS Estimates for BioNTech Decreased by Analyst
BioNTech SE (NASDAQ:BNTX) Short Interest Update
Vaccine Stocks Fall After MAGA Announces Anti-Vaxx Health Secretary: RFK Jr.
BioNTech (NASDAQ:BNTX) Shares Gap Down - Here's What Happened
Pharma Stocks Take Nose Dive After Trump Announces RFK Jr. For HHS
BioNTech (NASDAQ:BNTX) Given Buy Rating at Canaccord Genuity Group
Germany’s BioNTech buys China’s Biotheus in US$800 million push into cancer drugs | South China Morning Post
BNTX to Boost Oncology Pipeline With Biotheus Acquisition, Stock Up - November 14, 2024 - Zacks.com
Biontech acquiring PM-8002 through $950M Biotheus buyout | BioWorld
BioNTech to Acquire Biotheus for $800 Million to Expand Oncology Portfolio
BioNTech To Buy Biotheus In Upfront Payment Of $800 Mln
BioNTech to Acquire Biotheus to Boost Oncology Strategy | The Manila Times
Baillie Gifford & Co. Acquires 31,773 Shares of BioNTech SE (NASDAQ:BNTX)
TD Cowen Keeps Their Buy Rating on Roivant Sciences (ROIV) | Markets Insider
US Bancorp DE Trims Holdings in BioNTech SE (NASDAQ:BNTX)
BioNTech (NASDAQ:BNTX) Upgraded to Buy at The Goldman Sachs Group
The Goldman Sachs Group Upgrades BioNTech (NASDAQ:BNTX) to Buy
Goldman Sachs upgrades BioNTech to buy, sees stock surging more than 25%
FY2024 EPS Estimates for BioNTech Cut by HC Wainwright
BioNTech SE (NASDAQ:BNTX) Shares Sold by Robeco Institutional Asset Management B.V.
Van ECK Associates Corp Sells 25,216 Shares of BioNTech SE (NASDAQ:BNTX)
BioNTech SE (NASDAQ:BNTX) Receives $135.54 Consensus Target Price from Brokerages
Robeco Institutional Asset Management B.V. Cuts Stake in BioNTech SE (NASDAQ:BNTX)
Van ECK Associates Corp Reduces Stock Position in BioNTech SE (NASDAQ:BNTX)
BioNTech stock target cut to $122 from $132 by TD Cowen By Investing.com
TD Cowen Has Lowered Expectations for BioNTech (NASDAQ:BNTX) Stock Price
BioNTech (NASDAQ:BNTX) Announces Quarterly Earnings Results
BioNTech SE (BNTX) Q3 2024 Earnings Call Highlights: Revenue Surge and Strategic Advancements ... By GuruFocus
BMO raises BioNTech target to $126 on strong revenue By Investing.com
Earnings call: BioNTech reports growth in oncology and vaccine sectors By Investing.com
BioNTech Announces Third Quarter 2024 Financial Results and Corporate Update | The Manila Times
BioNTech Q3 Net Profit Rises; Backs FY24 Revenue Outlook Range, But At The Low End
BofA maintains Buy on BioNTech, price target at $150 By Investing.com
Adapted coronavirus vaccines drive BioNTech sales
Lodestone Wealth Management LLC Invests $8.37 Million in BioNTech SE (NASDAQ:BNTX)
BioNTech SE (NASDAQ:BNTX) Receives Consensus Recommendation of "Moderate Buy" from Brokerages
abrdn plc Acquires 173,969 Shares of BioNTech SE (NASDAQ:BNTX)
Blue Trust Inc. Increases Stock Position in BioNTech SE (NASDAQ:BNTX)
BioNTech to Host Innovation Series R&D Day on November 14, 2024 | The Manila Times
International Assets Investment Management LLC Takes Position in BioNTech SE (NASDAQ:BNTX)
China Universal Asset Management Co. Ltd. Buys 7,340 Shares of BioNTech SE (NASDAQ:BNTX)
Metastatic Melanoma Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and Barriers
BioNTech SE (NASDAQ:BNTX) Sees Significant Increase in Short Interest
BioNTech (BNTX) Set to Announce Earnings on Monday
DekaBank Deutsche Girozentrale Has $56.89 Million Position in BioNTech SE (NASDAQ:BNTX)
Will Non-COVID Drugs Again Boost Pfizer's Top Line in Q3 Earnings? - October 28, 2024 - Zacks.com
BioNTech to Report Q3 Earnings: Is a Beat in the Cards? - October 25, 2024 - Zacks.com
Osiris Therapeutics (OTCMKTS:OSIR) versus BioNTech (NASDAQ:BNTX) Financial Review
Latest news
MicroStrategy Stock Surges as Bitcoin price rises to fresh record above $94K
Nasdaq futures decline, Nvidia shares dip following the earnings report
Nvidia shares rallied on AI spending ahead of Nvidia Q3 earnings 2024
